GLCE
Basic information
Region (hg38): 15:69160584-69272217
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLCE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 18 | 1 | 2 |
Variants in GLCE
This is a list of pathogenic ClinVar variants found in the GLCE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-69255858-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
15-69255910-A-G | not specified | Uncertain significance (Jun 05, 2023) | ||
15-69255920-G-T | not specified | Uncertain significance (Feb 17, 2022) | ||
15-69255927-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
15-69255964-A-C | not specified | Uncertain significance (Jan 18, 2022) | ||
15-69256008-G-A | not specified | Likely benign (Mar 27, 2023) | ||
15-69256011-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
15-69256054-A-G | Benign (Jul 16, 2018) | |||
15-69256245-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
15-69256323-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
15-69256345-A-G | not specified | Uncertain significance (Mar 28, 2024) | ||
15-69261171-A-G | not specified | Uncertain significance (Dec 02, 2021) | ||
15-69261260-A-C | not specified | Uncertain significance (Dec 12, 2023) | ||
15-69268261-G-T | not specified | Uncertain significance (Jun 19, 2024) | ||
15-69268421-G-T | not specified | Uncertain significance (Sep 22, 2023) | ||
15-69268493-A-T | not specified | Uncertain significance (Jun 10, 2024) | ||
15-69268521-C-G | Benign (Jul 16, 2018) | |||
15-69268580-C-G | not specified | Uncertain significance (Mar 17, 2023) | ||
15-69268738-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
15-69268747-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
15-69268748-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
15-69268753-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
15-69268841-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
15-69268939-A-C | not specified | Uncertain significance (Apr 11, 2023) | ||
15-69269009-G-A | not specified | Uncertain significance (Apr 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GLCE | protein_coding | protein_coding | ENST00000261858 | 3 | 111634 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.654 | 0.346 | 125722 | 0 | 25 | 125747 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.71 | 242 | 329 | 0.735 | 0.0000168 | 4076 |
Missense in Polyphen | 55 | 120.24 | 0.45744 | 1415 | ||
Synonymous | 0.708 | 110 | 120 | 0.918 | 0.00000594 | 1182 |
Loss of Function | 3.43 | 4 | 20.9 | 0.191 | 0.00000107 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000416 | 0.000416 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Converts D-glucuronic acid residues adjacent to N- sulfate sugar residues to L-iduronic acid residues, both in maturing heparan sulfate (HS) and heparin chains. This is important for further modifications that determine the specificity of interactions between these glycosaminoglycans and proteins. {ECO:0000269|PubMed:20118238}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metabolism of carbohydrates;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosaminoglycan metabolism;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.234
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.47
Haploinsufficiency Scores
- pHI
- 0.327
- hipred
- Y
- hipred_score
- 0.626
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.111
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Glce
- Phenotype
- respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- heparan sulfate proteoglycan biosynthetic process;heparin biosynthetic process
- Cellular component
- Golgi membrane;Golgi apparatus;integral component of membrane
- Molecular function
- racemase and epimerase activity, acting on carbohydrates and derivatives;heparosan-N-sulfate-glucuronate 5-epimerase activity